These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Introduction to the background, principles, and state of the art in suicide gene therapy. Niculescu-Duvaz I; Springer CJ Mol Biotechnol; 2005 May; 30(1):71-88. PubMed ID: 15805578 [TBL] [Abstract][Full Text] [Related]
10. Gene directed enzyme prodrug therapy for ovarian cancer: could GDEPT become a promising treatment against ovarian cancer? Nawa A; Tanino T; Luo C; Iwaki M; Kajiyama H; Shibata K; Yamamoto E; Ino K; Nishiyama Y; Kikkawa F Anticancer Agents Med Chem; 2008 Feb; 8(2):232-9. PubMed ID: 18288924 [TBL] [Abstract][Full Text] [Related]
11. Direct retroviral delivery of human cytochrome P450 2B6 for gene-directed enzyme prodrug therapy of cancer. Kan O; Griffiths L; Baban D; Iqball S; Uden M; Spearman H; Slingsby J; Price T; Esapa M; Kingsman S; Kingsman A; Slade A; Naylor S Cancer Gene Ther; 2001 Jul; 8(7):473-82. PubMed ID: 11498768 [TBL] [Abstract][Full Text] [Related]
12. Recent developments in gene-directed enzyme prodrug therapy (GDEPT) for cancer. Niculescu-Duvaz I; Cooper RG; Stribbling SM; Heyes JA; Metcalfe JA; Springer CJ Curr Opin Mol Ther; 1999 Aug; 1(4):480-6. PubMed ID: 11713763 [TBL] [Abstract][Full Text] [Related]
13. Dendrimers as Non-Viral Vectors in Gene-Directed Enzyme Prodrug Therapy. Chis AA; Dobrea CM; Rus LL; Frum A; Morgovan C; Butuca A; Totan M; Juncan AM; Gligor FG; Arseniu AM Molecules; 2021 Oct; 26(19):. PubMed ID: 34641519 [TBL] [Abstract][Full Text] [Related]
17. Recent progress in gene-directed enzyme prodrug therapy: an emerging cancer treatment. Both GW Curr Opin Mol Ther; 2009 Aug; 11(4):421-32. PubMed ID: 19649987 [TBL] [Abstract][Full Text] [Related]
18. Activation of oxazaphosphorines by cytochrome P450: application to gene-directed enzyme prodrug therapy for cancer. Roy P; Waxman DJ Toxicol In Vitro; 2006 Mar; 20(2):176-86. PubMed ID: 16293390 [TBL] [Abstract][Full Text] [Related]
19. Enzyme/abzyme prodrug activation systems: potential use in clinical oncology. Nishi Y Curr Pharm Des; 2003; 9(26):2113-30. PubMed ID: 14529409 [TBL] [Abstract][Full Text] [Related]
20. Gene-directed enzyme prodrug therapy for prostate cancer in a mouse model that imitates the development of human disease. Martiniello-Wilks R; Dane A; Voeks DJ; Jeyakumar G; Mortensen E; Shaw JM; Wang XY; Both GW; Russell PJ J Gene Med; 2004 Jan; 6(1):43-54. PubMed ID: 14716676 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]